Registry for people with Takayasu arteritis
Part of Heart & circulation, Skin clinical trials.
This is a patient registry that collects information about people with Takayasu arteritis. It helps researchers better understand the condition and how it affects blood flow in the arms and other major vessels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your Takayasu arteritis symptoms started before age 40
- You have arm or leg muscle pain/fatigue when using the limb (cldudication)
- Your doctor has found weaker/low pulse in one or both upper arms (brachial pulse)
- Your blood pressure in the two arms differs by more than 10 mm Hg
- One of these was heard on exam: a whooshing sound (bruit) over the collarbone areas (subclavian) or belly aorta
- Imaging (arteriogram/artery scan) shows artery narrowing or blockage in certain large-vessel areas, not from common wear-and-tear causes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether gentle, repeated blood pressure cuff inflations on the arm can improve blood flow to the brain in people with Takayasu arteritis. It's for those with inactive disease and narrowed brain arteries but who still have low brain blood flow.
This trial studies treatment options for people age 14 and older with severe, active Takayasu arteritis causing major circulation problems and organ strain. It may help reduce inflammation and complications when the disease is flaring and difficult to control.
This UK-based study uses a questionnaire to learn about how people with Takayasu arteritis (a rare type of vasculitis) are treated and what they think about their care. If you have TAK, your answers can help doctors understand how to better manage this condition.
This study builds a nationwide list (registry) of people with certain autoimmune or inflammation-related illnesses. It helps researchers understand these diseases better over time, which can guide future care.
This trial compares a personalized treatment plan based on your specific disease markers to standard care, aiming to find which is more effective and safer for active Takayasu's arteritis. It may help researchers learn how to better control inflammation and prevent flares.
This trial tests a medication called secukinumab for people with active, severe Takayasu arteritis, a disease that causes inflammation in large blood vessels. The goal is to see if secukinumab can help control the disease better than standard treatments alone.
Hear when a new Takayasu Arteritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.